Ethyl 4-(4-chlorophenyl)-1,6-dimethyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Catalog No. :
ACARQL369
CAS No. :
302821-62-1
Molecular Formula :
C15H17ClN2O3
Molecular Weight :
308.77

IUPAC Name:ethyl 4-(4-chlorophenyl)-1,6-dimethyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Ethyl 4-(4-chlorophenyl)-1,6-dimethyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$76.00Login to see priceInquiryInquiry
5g95%$226.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4-(4-chlorophenyl)-1,6-dimethyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
IUPAC Nameethyl 4-(4-chlorophenyl)-1,6-dimethyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
MDL No.MFCD00718037
Molecular FormulaC15H17ClN2O3
Molecular Weight308.77
SMILESO=C(C1=C(C)N(C)C(NC1C2=CC=C(Cl)C=C2)=O)OCC
InChI KeyXHMRHHURCAQZLY-UHFFFAOYSA-N
SynonymEthyl 4-(4-chlorophenyl)-1,6-dimethyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate;5-Pyrimidinecarboxylic acid, 4-(4-chlorophenyl)-1,2,3,4-tetrahydro-1,6-dimethyl-2-oxo-, ethyl ester;ET 4-(4-CL-PHENYL)-1,6-DIMETHYL-2-OXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBOXYLATE
CAS No.302821-62-1

Synthetic Route by SureRoute

1. ACARQL369 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMSOG753 route compound structure diagram
    ACMSOG7535948-71-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACARQL369 route product structure diagram
    ACARQL369302821-62-1
Inquiry

2. ACARQL369 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  4. Then
  5. ACARQL369 route product structure diagram
    ACARQL369302821-62-1
Inquiry

Comments (0)